You are here

Article info

Article menu
Immunotherapy biomarkers
Original research
Cross-cohort analysis identified an immune checkpoint-based signature to predict the clinical outcomes of neuroblastoma

Authors

  • Liang Zeng Department of Pathology, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangdong Provincial Clinical Research Center for Child Health, National Children’s Medical Center for South Central Region, Guangzhou, China PubMed articlesGoogle scholar articles
  • Hui Xu Department of Pathology, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangdong Provincial Clinical Research Center for Child Health, National Children’s Medical Center for South Central Region, Guangzhou, China PubMed articlesGoogle scholar articles
  • Shu-Hua Li Molecular Diagnosis and Gene Testing Center, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China PubMed articlesGoogle scholar articles
  • Shuo-Yu Xu Department of General Surgery, Southern Medical University Nanfang Hospital, Guangzhou, ChinaBio-totem Pte. Ltd, Foshan, China PubMed articlesGoogle scholar articles
  • Kai Chen Department of Pathology, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangdong Provincial Clinical Research Center for Child Health, National Children’s Medical Center for South Central Region, Guangzhou, China PubMed articlesGoogle scholar articles
  • Liang-Jun Qin Department of Pathology, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangdong Provincial Clinical Research Center for Child Health, National Children’s Medical Center for South Central Region, Guangzhou, China PubMed articlesGoogle scholar articles
  • Lei Miao Guangzhou Institute of Paediatrics, Guangzhou Women and Children’s Medical Center, Guangzhou Medical University, Guangdong Provincial Clinical Research Center for Child Health,Guangdong Provincial Key Laboratory of Research in Structural Birth Defect Disease, National Children’s Medical Center for South Central Region, Guangzhou, China PubMed articlesGoogle scholar articles
  • Fang Wang Department of Molecular Diagnostics, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, Guangzhou, China PubMed articlesGoogle scholar articles
  • Ling Deng Department of Molecular Diagnostics, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, Guangzhou, China PubMed articlesGoogle scholar articles
  • Feng-Hua Wang Department of Thoracic Surgery, Guangzhou Women and Children’s Medical Center, Guangzhou Medical University, Guangzhou, China PubMed articlesGoogle scholar articles
  • Le Li Department of Thoracic Surgery, Guangzhou Women and Children’s Medical Center, Guangzhou Medical University, Guangzhou, China PubMed articlesGoogle scholar articles
  • Sha Fu Guangdong Provincial Key Laboratory of Malignant Tumour Epigenetics and Gene Regulation, Cellular & Molecular Diagnostics Center, Sun Yat-Sen Memorial Hospital, Guangzhou, China PubMed articlesGoogle scholar articles
  • Na Liu Department of Experimental Research, State Key Laboratory of Oncology in Southern China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University Cancer Center, Guangzhou, China PubMed articlesGoogle scholar articles
  • Ran Wang Department of Pathology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China PubMed articlesGoogle scholar articles
  • Ying-Qing Li State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center; Collaborative Innovation Center of Cancer Medicine, Guangzhou, China PubMed articlesGoogle scholar articles
  • Hai-Yun Wang Department of Pathology, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangdong Provincial Clinical Research Center for Child Health, National Children’s Medical Center for South Central Region, Guangzhou, ChinaGuangzhou Institute of Paediatrics, Guangzhou Women and Children’s Medical Center, Guangzhou Medical University, Guangdong Provincial Clinical Research Center for Child Health,Guangdong Provincial Key Laboratory of Research in Structural Birth Defect Disease, National Children’s Medical Center for South Central Region, Guangzhou, China PubMed articlesGoogle scholar articles

Citation

Zeng L, Xu H, Li S, et al
Cross-cohort analysis identified an immune checkpoint-based signature to predict the clinical outcomes of neuroblastoma
Journal for ImmunoTherapy of Cancer 2023;11:e005980. doi: 10.1136/jitc-2022-005980
Online issue publication 
May 02, 2023

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See http://creativecommons.org/licenses/by-nc/4.0/.